ŞİŞMAN, P. Et Al. 2016. The efficacy and safety of sorafenib treatment on iodide refractory metastatic differentiated thyroid carcinomas. 18th European Congress of Endocrinology , (Munich, Germany).

ŞİŞMAN, P., SUVERAN, M., ŞAHİN, A. B., ÖZ GÜL, Ö., CANDER, S., ERTÜRK, E., ... ERSOY, C.(2016). The efficacy and safety of sorafenib treatment on iodide refractory metastatic differentiated thyroid carcinomas . 18th European Congress of Endocrinology, Munich, Germany

ŞİŞMAN, PINAR Et Al. "The efficacy and safety of sorafenib treatment on iodide refractory metastatic differentiated thyroid carcinomas," 18th European Congress of Endocrinology, Munich, Germany, 2016

ŞİŞMAN, PINAR Et Al. "The efficacy and safety of sorafenib treatment on iodide refractory metastatic differentiated thyroid carcinomas." 18th European Congress of Endocrinology , Munich, Germany, 2016

ŞİŞMAN, P. Et Al. (2016) . "The efficacy and safety of sorafenib treatment on iodide refractory metastatic differentiated thyroid carcinomas." 18th European Congress of Endocrinology , Munich, Germany.

@conferencepaper{conferencepaper, author={PINAR ŞİŞMAN Et Al. }, title={The efficacy and safety of sorafenib treatment on iodide refractory metastatic differentiated thyroid carcinomas}, congress name={18th European Congress of Endocrinology}, city={Munich}, country={Germany}, year={2016}}